MOWRY BARBARA 4

4 · NATIONAL RESEARCH CORP · Filed Apr 18, 2018

Form 4

Period: 2018-04-17

Director

Transactions

Disposition to Issuer
Director Stock Option (Right to Buy)
2018-04-17−6,000→ 0 total
Exercise: $34.50Exp: 2025-05-07→ Class B Common Stock (6,000 underlying)
Disposition to Issuer
Director Stock Option (Right to Buy)
2018-04-17−6,000→ 0 total
Exercise: $37.78Exp: 2026-05-11→ Class B Common Stock (6,000 underlying)
Disposition to Issuer
Director Stock Option (Right to Buy)
2018-04-17−6,000→ 0 total
Exercise: $44.47Exp: 2027-05-09→ Class B Common Stock (6,000 underlying)
Disposition to Issuer
Director Stock Option (Right to Buy)
2018-04-17−12,000→ 0 total
Exercise: $43.91Exp: 2024-05-08→ Class B Common Stock (12,000 underlying)
Award
Common Stock
2018-04-17+6,902→ 6,902 total

Holdings

Director Stock Option (Right to Buy)
Exercise: $14.21From: 2016-05-07Exp: 2025-05-07→ Common Stock (36,000 underlying)
36,000
Director Stock Option (Right to Buy)
Exercise: $24.35From: 2018-05-09Exp: 2027-05-09→ Common Stock (36,000 underlying)
36,000
Director Stock Option (Right to Buy)
Exercise: $14.19From: 2017-05-11Exp: 2026-05-11→ Common Stock (36,000 underlying)
36,000
Director Stock Option (Right to Buy)
Exercise: $14.95From: 2015-05-08Exp: 2024-05-08→ Common Stock (72,000 underlying)
72,000

Footnotes (2)

[F1]On April 17, 2018, the Issuer completed a recapitalization whereby the Issuer exchanged one share of its then-existing class A common stock, plus $19.59 in cash, without interest, for each share of its then-existing class B common stock and, following such exchange, each share of class A common stock was reclassified as a share of Common Stock (the "Recapitalization").
[F2]Pursuant to the Recapitalization, all outstanding options to purchase class B common stock were vested in full and cancelled. In exchange for the option, the reporting person received one share of common stock, plus $19.59 in cash for each class B option, less the exercise price per share of the option.

Documents

1 file